Published in Arch Dermatol on April 01, 2002
The treatment of chronic recurrent oral aphthous ulcers. Dtsch Arztebl Int (2014) 1.86
Mucocutaneous lesions of Behcet's disease. Yonsei Med J (2007) 1.39
Behçet's disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis (2002) 1.27
Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients. Br J Ophthalmol (2006) 1.18
Behçet's disease. Arthritis Res Ther (2003) 1.07
Biological treatments in Behçet's disease: beyond anti-TNF therapy. Mediators Inflamm (2014) 1.07
Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome. Clin Exp Immunol (2008) 1.05
Update on the therapy of Behçet disease. Ther Adv Chronic Dis (2014) 1.01
New Evidence-Based Treatment Approach in Behçet's Disease. Patholog Res Int (2011) 0.93
Outcome measures used in clinical trials for Behçet syndrome: a systematic review. J Rheumatol (2014) 0.90
Differential diagnosis and management of Behçet syndrome. Nat Rev Rheumatol (2012) 0.86
Current and future treatments for Behçet's uveitis: road to remission. Int Ophthalmol (2013) 0.85
Interferons and their potential in the treatment of ocular inflammation. Clin Ophthalmol (2009) 0.84
Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features. Orphanet J Rare Dis (2013) 0.84
Managing Behçet's disease: An update on current and emerging treatment options. Ther Clin Risk Manag (2009) 0.82
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives. Mediators Inflamm (2015) 0.81
Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease. Case Rep Med (2012) 0.80
Short-Term Efficacy of Pudilan Keyanning Toothpaste in Treatment of Minor Recurrent Aphthous Ulcers. Evid Based Complement Alternat Med (2016) 0.79
Systemic treatments for noninfectious vitreous inflammation. Mediators Inflamm (2013) 0.78
Behçet's syndrome. Br J Ophthalmol (2003) 0.78
Behçet syndrome: from pathogenesis to novel therapies. Clin Exp Med (2014) 0.77
Long-term efficacy and safety of interferon α-2a therapy in severe refractory ophthalmic Behcet's disease. Clin Rheumatol (2016) 0.76
[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: Date: 02/07/2014]. Ophthalmologe (2014) 0.76
Intraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Behçet's disease. Graefes Arch Clin Exp Ophthalmol (2007) 0.76
Intestinal complications of Behçet's disease. BMJ Case Rep (2013) 0.75
Systemic treatment of vitreous inflammation. Mediators Inflamm (2012) 0.75
The great masquerader: Behcet's disease. BMJ Case Rep (2014) 0.75
Is Optimal Management of Recurrent Aphthous Stomatitis Possible? A Reality Check. J Clin Diagn Res (2016) 0.75
Behçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept. Libyan J Med (2012) 0.75
Behçet's disease: review with emphasis on dermatological aspects. An Bras Dermatol (2017) 0.75
Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Behçet's disease: a case report. Graefes Arch Clin Exp Ophthalmol (2003) 0.75
Kaposi's varicelliform eruption in association with rosacea. J Am Acad Dermatol (2004) 1.08
Demographic and clinical properties of juvenile-onset Behçet's disease: A controlled multicenter study. J Am Acad Dermatol (2007) 0.97
Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res (2007) 0.94
Nevus comedonicus syndrome: a case associated with multiple basal cell carcinomas and a rudimentary toe. Int J Dermatol (2005) 0.88
There might be a role for CD200 in the pathogenesis of autoimmune and inflammatory skin disorders. Med Sci Monit (2013) 0.83
Axis I and Axis II diagnoses in patients with chronic idiopathic urticaria. J Psychosom Res (2008) 0.83
A case of erythema elevatum diutinum associated with breast carcinoma. Int J Dermatol (2005) 0.83
Prognostic value of Ki-67, CD31 and epidermal growth factor receptor expression in basal cell carcinoma. J Dermatol (2003) 0.82
Choice of immunosuppressants and the risk of warts in renal transplant recipients. Acta Derm Venereol (2008) 0.80
Identification of recurrent mutations in the ARS (component B) gene encoding SLURP-1 in two families with mal de Meleda. J Invest Dermatol (2003) 0.80
A recurrent mutation in the ARS (component B) gene encoding SLURP-1 in Turkish families with mal de Meleda: evidence of a founder effect. J Invest Dermatol (2003) 0.79
Quality of life in patients with chronic idiopathic urticaria: the impact of Axis I and Axis II psychiatric disorders. Gen Hosp Psychiatry (2008) 0.79
[Psychopharmacological treatment and quality of life in obsessive compulsive disorder]. Turk Psikiyatri Derg (2008) 0.77
Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB. Photodermatol Photoimmunol Photomed (2008) 0.76
Treatment of arsenical keratosis and Bowen's disease with acitretin. Int J Dermatol (2002) 0.76
Invasive Trichophyton rubrum infection resembling blastomycosis in a patient with altered immune status during the course of chronic superficial Trichophyton rubrum infection. Eur J Dermatol (2007) 0.75
Unilateral erythema nodosum-like lesions and superficial thrombophlebitis together with ipsilateral thrombosis of the vena femoralis in Behçet's disease. Eur J Dermatol (2007) 0.75
Anticoagulant effect of Cupressus sempervirens. Phytother Res (2007) 0.75
Skin infections in 401 renal transplant recipients in southern Turkey. Exp Clin Transplant (2009) 0.75
Genital ORF. Eur J Dermatol (2008) 0.75